bazedoxifene has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adhikari, N; Bhattacharjee, M; Gupta, D; Pamnani, S; Panda, A; Rizvi, Z; Shehzad, S; Sijwali, PS; Sudhakar, R | 1 |
| Jain, SK; Kaur, R; Kaur, S; Kumar, M; Narendra, G; Raju, B; Sapra, B; Silakari, O; Singh, PK; Thakur, S; Tung, GK; Verma, H | 1 |
2 other study(ies) available for bazedoxifene and Neoplasms
| Article | Year |
|---|---|
Bazedoxifene, a Postmenopausal Drug, Acts as an Antimalarial and Inhibits Hemozoin Formation.
Topics: Animals; Antimalarials; Female; Heme; Hemeproteins; Hemoglobins; Humans; Indoles; Malaria; Malaria, Falciparum; Male; Mice; Neoplasms; Osteoporosis, Postmenopausal; Plasmodium falciparum; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Tamoxifen | 2022 |
Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach.
Topics: Aldehyde Dehydrogenase 1 Family; Aldehyde Dehydrogenase, Mitochondrial; Cyclophosphamide; Drug Repositioning; Humans; Molecular Docking Simulation; Neoplasms; Raloxifene Hydrochloride; Retinal Dehydrogenase | 2023 |